eFFECTOR Therapeutics Inc...

AI Score

0

Unlock

0.00
-0.00 (-100.00%)
At close: Feb 27, 2025, 3:56 PM
0.00
0.00%
Pre-market: Jan 16, 2025, 10:01 AM EST

eFFECTOR Therapeutics Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue n/a 3.55M 1.43M 42M n/a
Cost of Revenue 111K 53K 24K 21.83M 307K
Gross Profit -22.92M 3.5M 1.41M 20.17M -307K
Operating Income -33.84M -32.4M -31.9M 15.82M -28.61M
Interest Income 1.95M 439K 6K 67K 239K
Pretax Income -35.81M -22.66M 15.8M 14.56M -29.74M
Net Income -35.81M -12.93M 15.8M 14.21M -29.74M
Selling & General & Admin 10.93M 12.64M 13.37M 4.35M 4.71M
Research & Development 22.92M 23.31M 19.96M 21.83M 23.58M
Other Expenses n/a -3.55M -1.43M 9K n/a
Operating Expenses 33.84M 32.4M 31.9M 26.18M 28.3M
Interest Expense n/a 2.25M 1.76M 1.33M 1.38M
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 33.84M 32.4M 31.9M 26.18M 28.61M
Income Tax n/a -9.74M -24K 351K 135.14K
Shares Outstanding (Basic) 2.19M 1.65M 1.62M 598.56K 552.43K
Shares Outstanding (Diluted) 2.19M 1.65M 1.62M 598.56K 552.43K
EPS (Basic) -16.37 -7.85 9.78 23.74 -53.83
EPS (Diluted) -16.37 -7.85 9.78 23.74 -53.83
EBITDA -33.73M -32.4M -31.9M 16.05M -28.3M
Depreciation & Amortization 111K 53K 24K 160K 307K